RE:RE:RE:RE:RE:RE:Great News plus low volume equals continued drop in priceGV, ROTFLMAO...i am well trained and practiced in the art of writing to the crowd and this (investment MB's) is comedy central most days..and when i post that pikupstix, etc. entertain me and i deserve i mean it (his pretenious self-aggrandizing self-importance is denuded by the fact he writes copy for a baby biotech, that is just so funny) ...and i write to the way others post, you i perceive a gentlemen so i write to you respectfully others well they provide me entertainment...ps i actually write business reports regularly, with the purpose to persuade and am quite successful at it, last report was about 120 pages (about average for what i write), was an industry/goverment advocacy piece and likely quite influential (well written, well researched, authoritative, etc., or so i was told by the government officials)...this MB is like comics found in bubblegum wrappers...ps risks i write about re. chinee, etc. are real based on experience...also no PIII from FDA is a huge sell signal as IMO FDA will not accept other country trial data exclusively for registration trials and US is likely 2 times bigger (revenue, profit, etc.) than ROW. i believe registration trials must be FDA approved and RVX should know this ( i suspect RVX will be required to make significant changes and additions to plan, IMO adding lipitor is one such buckle under, i also see a 208 arm by itself) regards